Articles

Leap Therapeutics Articles

January 4, 2021MarketScreenerNews

to Present at 39th Annual J.P. Morgan Healthcare Conference

(marketscreener.com) CAMBRIDGE, Mass., Jan. 4, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. , a biote... See more »
December 22, 2020PR NewswirePress Release

Leap Therapeutics Announces Publication of DKN-01 Mechanism of Action Data in Molecular Cancer Research

CAMBRIDGE, Mass., Dec. 22, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnolog... See more »
November 12, 2020BioSpaceNews

Leap Therapeutics Reports Third Quarter 2020 Financial Results

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and imm... See more »
November 10, 2020MarketScreenerNews

to Present at Stifel 2020 Healthcare Conference

(marketscreener.com) CAMBRIDGE, Mass., Nov. 10, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. , a biot... See more »
October 15, 2020PR NewswirePress Release

Leap Therapeutics to Present Esophagogastric Cancer Data at SITC 2020 Annual Meeting

CAMBRIDGE, Mass., Oct. 15, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnolog... See more »
September 25, 2020Seeking AlphaNews

The Good, Bad And Ugly Of Biopharma

September 24, 2020PR NewswirePress Release

Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01 for the Treatment of Gastric and Gastroesophageal Junction Cancer

/PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing ... See more »
September 9, 2020MarketScreenerNews

to Present at H.C. Wainwright 22nd Annual Global Investment Conference

(marketscreener.com) CAMBRIDGE, Mass., Sept. 9, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. , a biot... See more »
August 24, 2020MarketScreenerNews

Expands Leadership Team with Addition of Two Industry Veterans

(marketscreener.com) CAMBRIDGE, Mass., Aug. 24, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. , a biot... See more »
August 16, 2020Zolmax NewsNews

Leap Therapeutics Inc (NASDAQ:LPTX) Expected to Announce Earnings of -$0.17 Per Share

Brokerages forecast that Leap Therapeutics Inc (NASDAQ:LPTX) will post earnings per share (EPS) of ($... See more »
August 13, 2020BioSpaceNews

Leap Therapeutics Reports Second Quarter 2020 Financial Results

Leap Therapeutics, Inc., a biotechnology company focused on developing targeted and immuno-oncology t... See more »
July 1, 2020Zolmax NewsNews

Leap Therapeutics Inc (NASDAQ:LPTX) Expected to Post Earnings of -$0.26 Per Share

Equities research analysts expect Leap Therapeutics Inc (NASDAQ:LPTX) to report ($0.26) earnings per ... See more »
February 4, 2020PR NewswirePress Release

Leap Therapeutics to Present at 22nd Annual BIO CEO & Investor Conference

CAMBRIDGE, Mass., Feb. 4, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnolog... See more »
January 23, 2020centralchartsPress Release

Leap Therapeutics Presents Updated Data at the ASCO 2020 Gastrointestinal Cancers Symposium (ASCO GI) Global Meeting

Leap Therapeutics Presents Updated Data at the ASCO 2020 Gastrointestinal Cancers Symposium (ASCO GI)... See more »
September 17, 2019PR NewswirePress Release

Leap Therapeutics to Present Updated Data for DKN-01 Monotherapy and Paclitaxel Combination at the 2019 International Gynecologic Cancer Society Annual Global Meeting

CAMBRIDGE, Mass., Sept. 17, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX) today announc... See more »
April 3, 2019PR NewswirePress Release

Leap Therapeutics to Present at the 2019 Needham & Company 18th Annual Healthcare Conference

CAMBRIDGE, Mass., April 3, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnolo... See more »
April 1, 2019PR NewswirePress Release

Leap Therapeutics Reports Clinical Update and 2018 Financial Results

CAMBRIDGE, Mass., April 1, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnolo... See more »
March 18, 2019PR NewswirePress Release

Leap Therapeutics Presents at Society of Gynecologic Oncology 50th Annual Meeting on Women's Cancer

CAMBRIDGE, Mass., March 18, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX) today announce... See more »
March 8, 2019centralchartsPress Release

Leap Therapeutics to Present at the Society of Gynecologic Oncology 2019 Annual Meeting on Women's Cancer

CAMBRIDGE, Mass., March 8, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnolo... See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...